Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hedva Lerman

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Melanoma Research|November 10, 2007
Sentinel node-guided evaluation of drainage patterns for melanoma of the helix of the earThomas Shpitzer, Haim Gutman, Yoav Barnea, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 27, 2013
Paradoxical immune reconstitution inflammatory syndrome associated with rituximab-containing regimen in a patient with lymphomaJonathan Canaani, Sharon Amit, Jonathan Ben-Ezra, et al.
Medicine|March 6, 2016
The Value of PET/CT in Detecting Bone Marrow Involvement in Patients With Follicular LymphomaChava Perry, Hedva Lerman, Erel Joffe, et al.
Head & Neck|August 26, 2006
Lymphoscintigraphy for sentinel node mapping using a hybrid single photon emission CT (SPECT)/CT system in oral cavity squamous cell carcinomaAvi Khafif, Shlomo Schneebaum, Dan M Fliss, et al.
Psychopharmacology|September 28, 2007
Brain imaging study of the acute effects of Delta9-tetrahydrocannabinol (THC) on attention and motor coordination in regular users of marijuanaAviv Weinstein, Orit Brickner, Hedva Lerman, et al.
Plos One|April 14, 2017
DaT-SPECT assessment depicts dopamine depletion among asymptomatic G2019S LRRK2 mutation carriersMoran Artzi, Einat Even-Sapir, Hedva Lerman Shacham, et al.
Neuroimage. Clinical|September 7, 2018
FDG PET Parkinson's disease-related pattern as a biomarker for clinical trials in early stage diseaseDawn C Matthews, Hedva Lerman, Ana Lukic, et al.
NPJ Parkinson'S Disease|October 21, 2022
Neuromelanin and T<sub>2</sub>*-MRI for the assessment of genetically at-risk, prodromal, and symptomatic Parkinson's diseaseDafna Ben Bashat, Avner Thaler, Hedva Lerman Shacham, et al.
NPJ Parkinson'S Disease|March 4, 2022
Aberrant dopamine transporter and functional connectivity patterns in LRRK2 and GBA mutation carriersAmgad Droby, Moran Artzi, Hedva Lerman, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Melanoma Research|November 10, 2007
Sentinel node-guided evaluation of drainage patterns for melanoma of the helix of the earThomas Shpitzer, Haim Gutman, Yoav Barnea, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 27, 2013
Paradoxical immune reconstitution inflammatory syndrome associated with rituximab-containing regimen in a patient with lymphomaJonathan Canaani, Sharon Amit, Jonathan Ben-Ezra, et al.
Medicine|March 6, 2016
The Value of PET/CT in Detecting Bone Marrow Involvement in Patients With Follicular LymphomaChava Perry, Hedva Lerman, Erel Joffe, et al.
Head & Neck|August 26, 2006
Lymphoscintigraphy for sentinel node mapping using a hybrid single photon emission CT (SPECT)/CT system in oral cavity squamous cell carcinomaAvi Khafif, Shlomo Schneebaum, Dan M Fliss, et al.
Psychopharmacology|September 28, 2007
Brain imaging study of the acute effects of Delta9-tetrahydrocannabinol (THC) on attention and motor coordination in regular users of marijuanaAviv Weinstein, Orit Brickner, Hedva Lerman, et al.
Plos One|April 14, 2017
DaT-SPECT assessment depicts dopamine depletion among asymptomatic G2019S LRRK2 mutation carriersMoran Artzi, Einat Even-Sapir, Hedva Lerman Shacham, et al.
Neuroimage. Clinical|September 7, 2018
FDG PET Parkinson's disease-related pattern as a biomarker for clinical trials in early stage diseaseDawn C Matthews, Hedva Lerman, Ana Lukic, et al.
NPJ Parkinson'S Disease|October 21, 2022
Neuromelanin and T<sub>2</sub>*-MRI for the assessment of genetically at-risk, prodromal, and symptomatic Parkinson's diseaseDafna Ben Bashat, Avner Thaler, Hedva Lerman Shacham, et al.
NPJ Parkinson'S Disease|March 4, 2022
Aberrant dopamine transporter and functional connectivity patterns in LRRK2 and GBA mutation carriersAmgad Droby, Moran Artzi, Hedva Lerman, et al.
Pageof 4